纳斯达克： -- -- --

最近浏览

实时行情

意见反馈

IQVIA Holdings, Inc

NYSE:IQV 延时15分钟
  • 今开：--
    昨收：--
  • 今日区间：--
    52周区间：--
  • 成交量：--
    成交额：--
  • 市 值：--
    市盈率：--
  • 振幅：
    每股收益：
成交量

董事会

Ari Bousbib
Ari Bousbib currently works at IQVIA, Inc., as Chairman & Chief Executive Officer from 2016, IQVIA Commercial Deutschland GmbH, as Chairman, President & Chief Executive Officer from 2016, IQVIA Holdings, Inc., as Chairman, President & Chief Executive Officer from 2016, The Home Depot, Inc., as Independent Director from 2007, and JogoHealth, Inc., as Director from 2019. Mr. Bousbib also formerly worked at IMS Health Holdings, Inc., as Chairman, President & Chief Executive Officer from 2010 to 2016, Best Buy Co., Inc., as Director in 2007, Otis Mobility SA, as Director, United Technologies Corp., as Chief Strategy & Development Officer from 1997 to 2010, Carrier Corp., as President from 2008 to 2010, Otis Elevator Co., as President from 2008 to 2010, Booz Allen Hamilton, Inc., as Associate from 1987 to 1992, Carrier Fire & Security Americas Corp., as President from 2008 to 2010, UTC Power LLC, as President from 2008 to 2010, and IQVIA RDS, Inc., as President. Mr. Bousbib received his Masters Business Admin degree from The Trustees of Columbia University in The City of New York and graduate degree from Ecole Sp ciale des Travaux Publics.
John M. Leonard
John M. Leonard is currently the President, Chief Executive Officer & Director at Intellia Therapeutics, Inc. He is also a Director at the Biotechnology Innovation Organization, IFM Therapeutics LLC, IQVIA Holdings, Inc., 3T Biosciences, Inc., IFM Cinque, Inc., IFM Continua, Inc., IFM Quattro, Inc., and an Executive Partner at Tyree & D Angelo Partners Management LP. Previously, Dr. Leonard served as an Independent Director at Chimerix, Inc. from 2014 to 2018. He was also an Independent Director at Quintiles Transnational Holdings, Inc. and Vitae Pharmaceuticals LLC from 2015 to 2016. Prior to that, he worked as a Senior Director-Clinical Research at G.H. Besselaar Associates. From 1992 to 2012, he held the position of Senior VP-Pharmaceuticals, Research & Development at Abbott Laboratories. In 2013 and 2014, he served as the CSO, SVP-Pharmaceutical Research & Development at AbbVie, Inc.Dr. Leonard completed his undergraduate degree at the University of Wisconsin and obtained a doctorate degree from The Johns Hopkins University School of Medicine.
John P. Connaughton
John P. Connaughton is Chairman at Bain Capital Private Equity LP since 2026 and has been with Bain Capital since 1989. He is Managing Partner at Bain Capital LP since 1997. He serves as Director at iHeartMedia Capital. I LLC, The Brigham & Women's Hospital, Inc., Boston Basketball Partners LLC, Air Medical Group Holdings, Inc., Boston Celtics, Inc., iHeartCommunications, Inc., Roxbury Latin School, GreenLight Fund, Inc., and is an Independent Director at IQVIA Holdings, Inc. since 2016. He is Trustee at Berklee College of Music, McIntire School of Commerce Foundation, and UVa McIntire Foundation. Former roles include Director at AMC Entertainment, Inc. (2004 2009), FIS Capital Markets US LLC (2005 2012), Stericycle, Inc. (1999 2005), Loews Cineplex Entertainment Corp. (2004 2006), ProSiebenSat.1 Media SE (2003 2007), Quintiles Transnational Holdings, Inc. (2008 2016), EPOCH Senior Living, Inc. (2001 2007), Warner Music Group Corp. (2004 2011), Cumulus Media Partners LLC (2006 2008), iHeartMedia, Inc. (2007 2019), and Warner Chilcott Plc (2004 2013). Education includes an MBA from Harvard Business School and an undergraduate degree from McIntire School of Commerce, conferred in 1987.
Todd Benjamin Sisitsky
Todd Benjamin Sisitsky currently works at Aptalis Holdings, Inc., as Chairman from 2008, Immucor, Inc., as Director from 2011, Campaign for Tobacco-Free Kids, as Director, Confluent Medical Technologies, Inc., as Director, Convey Health Solutions, Inc., as Director from 2019, Dartmouth Medical School, as Director-Overseers Board, Tarrant Capital IP LLC, as President & Director, Grassroot Soccer, Inc., as Director, Healthscope Pathology Holdings Pty Ltd., as Director, Adare Pharma Solutions, Inc., as Director, IQVIA Holdings, Inc., as Independent Director from 2016, Osteon Holdings, Inc., as Director, Allogene Therapeutics, Inc., as Independent Director from 2018, Monogram Health, Inc., as Director from 2021, Convey Health Solutions Holdings, Inc., as Independent Director from 2019, Ellodi Pharmaceuticals, as Director, Monogram Health Holdings, Inc., as Director, TPG, Inc., as President & Director from 1992, Healthscope Pty Ltd., as Principal, Dartmouth College, as Trustee, and Tobacco Free Kids, as Member-Campaign Board. Mr. Sisitsky also formerly worked at Surgical Care Affiliates, Inc., as Chairman from 2013 to 2017, Biomet, Inc., as Director, Endo Generics Holdings, Inc., as Director from 2012 to 2015, IASIS Healthcare LLC, as Director, Aptalis Pharma Canada ULC, as Director, Endo International Plc, as Director from 2016 to 2019, IMS Health Holdings, Inc., as Lead Independent Director from 2015 to 2016, IASIS Healthcare Corp., as Independent Director, Fenwal, Inc., as Director, Par Pharmaceutical Cos., Inc. (New Jersey), as Director from 2012 to 2015, Exactech, Inc., as Director, Oak Hill Capital Partners LP, as Principal from 1999 to 2000, Morgan Stanley & Co. LLC, as Principal, and Forstmann Little & Co., as Associate from 2001 to 2002. Mr. Sisitsky received his undergraduate degree from Dartmouth College and Masters Business Admin degree from Stanford Graduate School of Business.
John G. Danhakl
John G. Danhakl currently works at Arden Group, Inc., as Independent Director from 2011, WellSky Corp., as Director, Life Time, Inc., as Director, and various other companies. Mr. Danhakl also formerly worked at The Neiman Marcus Group LLC, as Director, Petco Animal Supplies, Inc., as Director, Rite Aid Corp., as Director from 1997 to 2006, and various other companies. Mr. Danhakl received his undergraduate degree in 1980 from the University of California, Berkeley and Masters Business Admin degree in 1985 from Harvard Business School.
James A. Fasano
James A. Fasano is currently Director at Cequel Communications Holdings LLC and Asurion LLC. He is Managing Director at Canada Pension Plan Investment Board Private Investments since 2004. Since 2016, Mr. Fasano serves as Independent Director at IQVIA Holdings, Inc. Formerly, Mr. Fasano was Director at Kinetic Concepts, Inc., IQVIA, Inc., Asurion LLC, IQVIA Solutions Canada, Inc., LHP Hospital Group, Inc., Asurion Protection Services LLC, Cequel Corp., and held non-executive and director roles at AWAS Aviation Capital DAC and RBC Capital Markets LLC. Mr. Fasano was Independent Director at IMS Health Holdings, Inc. from 2015 to 2016. Other former roles include Managing Director & Head of Portfolio Strategy at Canada Pension Plan Investment Board, Principal at Merrill Lynch & Co., Inc. in 2003, and Officer in the Canada Armed Forces. Education includes undergraduate studies at Royal Military College of Canada and an MBA from The University of Chicago Booth School of Business.
Colleen A. Goggins
Colleen A. Goggins currently works at Citymeals-on-Wheels, as Director, ZO Skin Health, Inc., as Director from 2020, IQVIA Holdings, Inc., as Independent Director from 2017, The Child Health Institute of New Jersey, as Director, Bayer AG, as Independent Member-Supervisory Board from 2017, Institute of International Education, Inc., as Trustee, Historic Morven, Inc., as Trustee, and The Nature Conservancy in New Jersey, as Trustee. Ms. Goggins also formerly worked at Johnson & Johnson, as Worldwide Chairman-Consumer & Personal Care Group from 2001 to 2011, Bausch Health Americas, Inc., as Director from 2014 to 2016, US-China Business Council, as Director, Bausch Health Cos., Inc., as Director from 2014 to 2016, National Foundation for the Center for Disease Control, as Director, Wisconsin Alumni Association, as Director, SIG Group AG, as Independent Non-Executive Director from 2018 to 2023, The Toronto-Dominion Bank, as Independent Director from 2012 to 2025, KraussMaffei Group GmbH, as Member-Supervisory Board from 2013 to 2016, and Personal Products Co., as President from 1994 to 1995. Ms. Goggins received her undergraduate degree in 1977 from the University of Wisconsin and graduate degree from Kellogg School of Management.
Carol J. Burt
Carol J. Burt currently works at The Nature Conservancy in Colorado, as Co-Chairman-Trustees Board, ResMed, Inc., as Independent Director from 2013, Global Medical Response, Inc., as Director from 2019, WellDyneRx, LLC, as Director from 2017, Colorado Historical Society, as Treasurer & Director, IQVIA Holdings, Inc., as Independent Director from 2019, Hillcour, Inc., as Director, The International Women's Forum, as Member, National Association of Corporate Directors, as Member, Consonance Capital Partners LLC, as Operating Council from 2013, Women Corporate Directors, as Member, Women's Forum of Colorado, as Member, and Burt-Hilliard Investments, as Principal from 2008. Ms. Burt also formerly worked at Women's Foundation of Colorado, as Chairman from 2012 to 2013, Transitional Hospitals Corp., as Director from 1996 to 1997, Vanguard Health Systems, Inc., as Independent Director from 2012 to 2013, Envision Healthcare Corp., as Director, Envision Healthcare Holdings, Inc., as Director in 2011, WCG Health Management, Inc., as Independent Director from 2011 to 2018, Keystone Peer Review Organization LLC, as Director from 2015 to 2017, Envision Healthcare Corp., as Independent Director from 2011 to 2018, Envision Healthcare, Inc., as Director, American Medical Response, Inc., as Treasurer & Senior Vice President from 1996 to 1997, Psilos Group Managers LLC, as Advisor from 2010 to 2011, Chase Securities, Inc., as MD & Head-Health Care Investment Banking Group from 1980 to 1996, Elevance Health, Inc., as Senior VP-Corporate Finance & Development from 1997 to 2007, and Arcus Financial Intelligence, Inc., as Advisory Board Member from 2008 to 2011. Ms. Burt received her undergraduate degree in 1980 from the University of Houston.
Leslie Wims Morris
Leslie Wims Morris is currently the Vice Chairman at Dance Theatre of Harlem, Managing Director-Consumer & Community Banking at JPMorgan Chase & Co., and an Independent Director at IQVIA Holdings, Inc. She previously held positions as Vice President-Executive Partnerships at American Express Co., Senior VP-Strategy & Business Development at Broadridge Financial Solutions, Inc., and Senior Vice President at Jefferies LLC. Morris received her undergraduate degree from Yale University and her MBA from Harvard Business School.
Sheila A. Stamps
Ms. Sheila A. Stamps is an Independent Director at IQVIA Holdings, Inc., an Independent Director at MFA Financial, Inc. and a Strategic Advisor at Forest Road Acquisition Corp. II. She is on the Board of Directors at IQVIA Holdings, Inc., MFA Financial, Inc., Institute for the International Education of Students, National Association of Corporate Directors (New York) and Bankinter Foundation of Innovation. Ms. Stamps was previously employed as an Independent Director by Forest Road Acquisition Corp., an Independent Director by Pitney Bowes, Inc., an Independent Director by Atlas Air Worldwide Holdings, Inc., an Independent Director by CIT Group, Inc., a Commissioner by New York State Insurance Fund, an Executive Vice President by Design, Build, Integrate LLC, an EVP-Corporate Strategy & Investor Relations by Dreambuilder Investments LLC, a Managing Director by Golden Seeds, Inc., a Director-Pension Investments & Cash Management by New York State Common Retirement Fund, a Managing Director & Head-Relationship Management by Bank of America Corp., a Managing Director & Head-Relationship Management by FleetBoston Financial Corp., a Managing Director-Asset Backed Securitization by Bank One Europe Ltd., a MD & Head-European Asset Backed Securitization by Bank One Corp., and a MD & Head-European Asset Backed Securitization by First Chicago Corp. She also served on the board at CIT Bank NA and CIT Bank (Utah). She received her undergraduate degree from Duke University and an MBA from The University of Chicago.
William G. Kaelin
William G. Kaelin is the founder of Tango Therapeutics Sub, Inc. (founded in 2017), Cedilla Therapeutics, Inc. (founded in 2017), and Tango Therapeutics, Inc. (founded in 2017). Current jobs include Independent Director at Eli Lilly & Co. since 2012, Director at The Damon Runyon Cancer Research Foundation, Director at LifeMine Therapeutics, Inc. since 2021, Director at IconOVir Bio, Inc. since 2022, Independent Director at IQVIA Holdings, Inc. starting 2025, Trustee at Duke University, Professor at Dana-Farber Cancer Institute, Inc., Professor at The Brigham & Women's Hospital, Inc. since 2002, Member of the National Academy of Sciences, Member of the American Academy of Arts & Sciences, Member of the Association of American Physicians, Member of Dana-Farber, Member of the American Society of Clinical Investigation, Professor at Harvard Medical School since 2002, and Advisor at Casdin Capital. Former jobs include Chief Resident & House Officer at The Johns Hopkins Hospital, Inc., Member-Advisory Board at National Cancer Institute, Member of the National Academy of Medicine (United States), Member of the American College of Physicians, Inc., and Trustee of the American Association for Cancer Research. Education includes undergraduate degree from Duke University in 1982 and a doctorate from Duke University School of Medicine.